Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001401914-19-000099
Filing Date
2019-11-21
Accepted
2019-11-21 19:54:18
Documents
3
Period of Report
2019-11-20

Document Format Files

Seq Description Document Type Size
1 FORM 3 wf-form3_157438404155349.html 3  
1 FORM 3 wf-form3_157438404155349.xml 3 1687
2 POWER OF ATTORNEY poacb.htm EX-24 4464
3 GRAPHIC poacb001.jpg GRAPHIC 215345
  Complete submission text file 0001401914-19-000099.txt   304434
Mailing Address C/O ZIMMER, INC. P.O. BOX 708 WARSAW IN 46580
Business Address
Blanchard Cheryl R (Reporting) CIK: 0001326530 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36395 | Film No.: 191238457

Mailing Address 3655 NOBEL DRIVE SUITE 260 SAN DIEGO CA 92122
Business Address 3655 NOBEL DRIVE SUITE 260 SAN DIEGO CA 92122 858-926-7655
Dare Bioscience, Inc. (Issuer) CIK: 0001401914 (see all company filings)

EIN.: 204139823 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations